 | • レポートコード：MRC2-11QY02726 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアトピー性皮膚炎薬のグローバル市場について調査・分析したレポートです。種類別（注射可ROA、経口ROA、熱帯ROA）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アトピー性皮膚炎薬の競争状況、市場シェア ・世界のアトピー性皮膚炎薬市場：種類別市場規模 2015年-2020年（注射可ROA、経口ROA、熱帯ROA） ・世界のアトピー性皮膚炎薬市場：種類別市場規模予測 2021年-2026年（注射可ROA、経口ROA、熱帯ROA） ・世界のアトピー性皮膚炎薬市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のアトピー性皮膚炎薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のアトピー性皮膚炎薬市場分析：米国、カナダ ・ヨーロッパのアトピー性皮膚炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアトピー性皮膚炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアトピー性皮膚炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアトピー性皮膚炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：LEO Pharma、Mylan、Valeant、Bayer HealthCare、Encore Dermatology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized).
One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated with food allergy. It has been observed that these allergies mainly result from the cow’s milk, chicken eggs, peanuts, wheat, soy, nuts, and fish.
Market Analysis and Insights: Global Atopic Dermatitis Drugs Market
The global Atopic Dermatitis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Atopic Dermatitis Drugs Scope and Market Size
Atopic Dermatitis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Atopic Dermatitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Atopic Dermatitis Drugs market is segmented into
Injectable ROA
Oral ROA
Tropical ROA
Segment by Application, the Atopic Dermatitis Drugs market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Atopic Dermatitis Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Atopic Dermatitis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Atopic Dermatitis Drugs Market Share Analysis
Atopic Dermatitis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Atopic Dermatitis Drugs business, the date to enter into the Atopic Dermatitis Drugs market, Atopic Dermatitis Drugs product introduction, recent developments, etc.
The major vendors covered:
LEO Pharma
Mylan
Valeant
Bayer HealthCare
Encore Dermatology
…
1 Study Coverage
1.1 Atopic Dermatitis Drugs Product Introduction
1.2 Market Segments
1.3 Key Atopic Dermatitis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Atopic Dermatitis Drugs Market Size Growth Rate by Type
1.4.2 Injectable ROA
1.4.3 Oral ROA
1.4.4 Tropical ROA
1.5 Market by Application
1.5.1 Global Atopic Dermatitis Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Atopic Dermatitis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Atopic Dermatitis Drugs Revenue 2015-2026
2.1.2 Global Atopic Dermatitis Drugs Sales 2015-2026
2.2 Global Atopic Dermatitis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Atopic Dermatitis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Atopic Dermatitis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Atopic Dermatitis Drugs Competitor Landscape by Players
3.1 Atopic Dermatitis Drugs Sales by Manufacturers
3.1.1 Atopic Dermatitis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Atopic Dermatitis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Atopic Dermatitis Drugs Revenue by Manufacturers
3.2.1 Atopic Dermatitis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Atopic Dermatitis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Atopic Dermatitis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Atopic Dermatitis Drugs Revenue in 2019
3.2.5 Global Atopic Dermatitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Atopic Dermatitis Drugs Price by Manufacturers
3.4 Atopic Dermatitis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Atopic Dermatitis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Atopic Dermatitis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Atopic Dermatitis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Atopic Dermatitis Drugs Market Size by Type (2015-2020)
4.1.1 Global Atopic Dermatitis Drugs Sales by Type (2015-2020)
4.1.2 Global Atopic Dermatitis Drugs Revenue by Type (2015-2020)
4.1.3 Atopic Dermatitis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Atopic Dermatitis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Atopic Dermatitis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Atopic Dermatitis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Atopic Dermatitis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Atopic Dermatitis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Atopic Dermatitis Drugs Market Size by Application (2015-2020)
5.1.1 Global Atopic Dermatitis Drugs Sales by Application (2015-2020)
5.1.2 Global Atopic Dermatitis Drugs Revenue by Application (2015-2020)
5.1.3 Atopic Dermatitis Drugs Price by Application (2015-2020)
5.2 Atopic Dermatitis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Atopic Dermatitis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Atopic Dermatitis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Atopic Dermatitis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Atopic Dermatitis Drugs by Country
6.1.1 North America Atopic Dermatitis Drugs Sales by Country
6.1.2 North America Atopic Dermatitis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Atopic Dermatitis Drugs Market Facts & Figures by Type
6.3 North America Atopic Dermatitis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Atopic Dermatitis Drugs by Country
7.1.1 Europe Atopic Dermatitis Drugs Sales by Country
7.1.2 Europe Atopic Dermatitis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Atopic Dermatitis Drugs Market Facts & Figures by Type
7.3 Europe Atopic Dermatitis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Atopic Dermatitis Drugs by Region
8.1.1 Asia Pacific Atopic Dermatitis Drugs Sales by Region
8.1.2 Asia Pacific Atopic Dermatitis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Atopic Dermatitis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Atopic Dermatitis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Atopic Dermatitis Drugs by Country
9.1.1 Latin America Atopic Dermatitis Drugs Sales by Country
9.1.2 Latin America Atopic Dermatitis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Atopic Dermatitis Drugs Market Facts & Figures by Type
9.3 Central & South America Atopic Dermatitis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Atopic Dermatitis Drugs by Country
10.1.1 Middle East and Africa Atopic Dermatitis Drugs Sales by Country
10.1.2 Middle East and Africa Atopic Dermatitis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Atopic Dermatitis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Atopic Dermatitis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 LEO Pharma
11.1.1 LEO Pharma Corporation Information
11.1.2 LEO Pharma Description and Business Overview
11.1.3 LEO Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 LEO Pharma Atopic Dermatitis Drugs Products Offered
11.1.5 LEO Pharma Related Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Description and Business Overview
11.2.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mylan Atopic Dermatitis Drugs Products Offered
11.2.5 Mylan Related Developments
11.3 Valeant
11.3.1 Valeant Corporation Information
11.3.2 Valeant Description and Business Overview
11.3.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Valeant Atopic Dermatitis Drugs Products Offered
11.3.5 Valeant Related Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Corporation Information
11.4.2 Bayer HealthCare Description and Business Overview
11.4.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer HealthCare Atopic Dermatitis Drugs Products Offered
11.4.5 Bayer HealthCare Related Developments
11.5 Encore Dermatology
11.5.1 Encore Dermatology Corporation Information
11.5.2 Encore Dermatology Description and Business Overview
11.5.3 Encore Dermatology Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Encore Dermatology Atopic Dermatitis Drugs Products Offered
11.5.5 Encore Dermatology Related Developments
11.1 LEO Pharma
11.1.1 LEO Pharma Corporation Information
11.1.2 LEO Pharma Description and Business Overview
11.1.3 LEO Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 LEO Pharma Atopic Dermatitis Drugs Products Offered
11.1.5 LEO Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Atopic Dermatitis Drugs Market Estimates and Projections by Region
12.1.1 Global Atopic Dermatitis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Atopic Dermatitis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Atopic Dermatitis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Atopic Dermatitis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Atopic Dermatitis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Atopic Dermatitis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Atopic Dermatitis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Atopic Dermatitis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Atopic Dermatitis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Atopic Dermatitis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Atopic Dermatitis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Atopic Dermatitis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Atopic Dermatitis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Atopic Dermatitis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Atopic Dermatitis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Atopic Dermatitis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Atopic Dermatitis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Atopic Dermatitis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Atopic Dermatitis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Atopic Dermatitis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Atopic Dermatitis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Atopic Dermatitis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Atopic Dermatitis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Atopic Dermatitis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Atopic Dermatitis Drugs Market Segments
Table 2. Ranking of Global Top Atopic Dermatitis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Atopic Dermatitis Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Injectable ROA
Table 5. Major Manufacturers of Oral ROA
Table 6. Major Manufacturers of Tropical ROA
Table 7. Global Atopic Dermatitis Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Atopic Dermatitis Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Atopic Dermatitis Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Atopic Dermatitis Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Atopic Dermatitis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Atopic Dermatitis Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Atopic Dermatitis Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Atopic Dermatitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Atopic Dermatitis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atopic Dermatitis Drugs as of 2019)
Table 16. Atopic Dermatitis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Atopic Dermatitis Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Atopic Dermatitis Drugs Price (2015-2020) (USD/Unit)
Table 19. Atopic Dermatitis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Atopic Dermatitis Drugs Product Type
Table 21. Date of International Manufacturers Enter into Atopic Dermatitis Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Atopic Dermatitis Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Atopic Dermatitis Drugs Sales Share by Type (2015-2020)
Table 25. Global Atopic Dermatitis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Atopic Dermatitis Drugs Revenue Share by Type (2015-2020)
Table 27. Atopic Dermatitis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Atopic Dermatitis Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Atopic Dermatitis Drugs Sales Share by Application (2015-2020)
Table 30. North America Atopic Dermatitis Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Atopic Dermatitis Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Atopic Dermatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Atopic Dermatitis Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Atopic Dermatitis Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Atopic Dermatitis Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Atopic Dermatitis Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Atopic Dermatitis Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Atopic Dermatitis Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Atopic Dermatitis Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Atopic Dermatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Atopic Dermatitis Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Atopic Dermatitis Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Atopic Dermatitis Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Atopic Dermatitis Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Atopic Dermatitis Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Atopic Dermatitis Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Atopic Dermatitis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Atopic Dermatitis Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Atopic Dermatitis Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Atopic Dermatitis Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Atopic Dermatitis Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Atopic Dermatitis Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Atopic Dermatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Atopic Dermatitis Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Atopic Dermatitis Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Atopic Dermatitis Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Atopic Dermatitis Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Atopic Dermatitis Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Atopic Dermatitis Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Atopic Dermatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Atopic Dermatitis Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Atopic Dermatitis Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Atopic Dermatitis Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Application (2015-2020)
Table 70. LEO Pharma Corporation Information
Table 71. LEO Pharma Description and Major Businesses
Table 72. LEO Pharma Atopic Dermatitis Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. LEO Pharma Product
Table 74. LEO Pharma Recent Development
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Major Businesses
Table 77. Mylan Atopic Dermatitis Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Mylan Product
Table 79. Mylan Recent Development
Table 80. Valeant Corporation Information
Table 81. Valeant Description and Major Businesses
Table 82. Valeant Atopic Dermatitis Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Valeant Product
Table 84. Valeant Recent Development
Table 85. Bayer HealthCare Corporation Information
Table 86. Bayer HealthCare Description and Major Businesses
Table 87. Bayer HealthCare Atopic Dermatitis Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer HealthCare Product
Table 89. Bayer HealthCare Recent Development
Table 90. Encore Dermatology Corporation Information
Table 91. Encore Dermatology Description and Major Businesses
Table 92. Encore Dermatology Atopic Dermatitis Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Encore Dermatology Product
Table 94. Encore Dermatology Recent Development
Table 95. Global Atopic Dermatitis Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 96. Global Atopic Dermatitis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 97. Global Atopic Dermatitis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 98. Global Atopic Dermatitis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 99. North America: Atopic Dermatitis Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 100. North America: Atopic Dermatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Europe: Atopic Dermatitis Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 102. Europe: Atopic Dermatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Asia Pacific: Atopic Dermatitis Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 104. Asia Pacific: Atopic Dermatitis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 105. Latin America: Atopic Dermatitis Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 106. Latin America: Atopic Dermatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Middle East and Africa: Atopic Dermatitis Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 108. Middle East and Africa: Atopic Dermatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 110. Key Challenges
Table 111. Market Risks
Table 112. Main Points Interviewed from Key Atopic Dermatitis Drugs Players
Table 113. Atopic Dermatitis Drugs Customers List
Table 114. Atopic Dermatitis Drugs Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Atopic Dermatitis Drugs Product Picture
Figure 2. Global Atopic Dermatitis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Injectable ROA Product Picture
Figure 4. Oral ROA Product Picture
Figure 5. Tropical ROA Product Picture
Figure 6. Global Atopic Dermatitis Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Atopic Dermatitis Drugs Report Years Considered
Figure 10. Global Atopic Dermatitis Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Atopic Dermatitis Drugs Sales 2015-2026 (K Units)
Figure 12. Global Atopic Dermatitis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Atopic Dermatitis Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Atopic Dermatitis Drugs Sales Market Share by Region in 2019
Figure 15. Global Atopic Dermatitis Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Atopic Dermatitis Drugs Revenue Market Share by Region in 2019
Figure 17. Global Atopic Dermatitis Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Atopic Dermatitis Drugs Revenue in 2019
Figure 19. Atopic Dermatitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Atopic Dermatitis Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Atopic Dermatitis Drugs Sales Market Share by Type in 2019
Figure 22. Global Atopic Dermatitis Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Atopic Dermatitis Drugs Revenue Market Share by Type in 2019
Figure 24. Global Atopic Dermatitis Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Atopic Dermatitis Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Atopic Dermatitis Drugs Sales Market Share by Application in 2019
Figure 27. Global Atopic Dermatitis Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Atopic Dermatitis Drugs Revenue Market Share by Application in 2019
Figure 29. North America Atopic Dermatitis Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Atopic Dermatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Atopic Dermatitis Drugs Sales Market Share by Country in 2019
Figure 32. North America Atopic Dermatitis Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Atopic Dermatitis Drugs Market Share by Type in 2019
Figure 38. North America Atopic Dermatitis Drugs Market Share by Application in 2019
Figure 39. Europe Atopic Dermatitis Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Atopic Dermatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Atopic Dermatitis Drugs Sales Market Share by Country in 2019
Figure 42. Europe Atopic Dermatitis Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Atopic Dermatitis Drugs Market Share by Type in 2019
Figure 54. Europe Atopic Dermatitis Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Atopic Dermatitis Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Atopic Dermatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Atopic Dermatitis Drugs Revenue Market Share by Region in 2019
Figure 59. China Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Atopic Dermatitis Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Atopic Dermatitis Drugs Market Share by Application in 2019
Figure 83. Latin America Atopic Dermatitis Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Atopic Dermatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Atopic Dermatitis Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Atopic Dermatitis Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Atopic Dermatitis Drugs Market Share by Type in 2019
Figure 94. Latin America Atopic Dermatitis Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Atopic Dermatitis Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Atopic Dermatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Atopic Dermatitis Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Atopic Dermatitis Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Atopic Dermatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Atopic Dermatitis Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Atopic Dermatitis Drugs Market Share by Application in 2019
Figure 107. North America Atopic Dermatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Atopic Dermatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Atopic Dermatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Atopic Dermatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Atopic Dermatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
犬アトピー性皮膚炎治療の世界市場（～2026年） Canine atopic dermatitis is a problem that is related to the skin, which when exposed to the allergens results in allergic symptoms. Market Analysis and Insights: Global Canine Atopic Dermatitis Treatment Market The global Canine Atopic Dermatitis Treatment market size is projected to reach US$ XX m…- 軽度・中等度アトピー性皮膚炎治療の世界市場（～2026年） Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often confined to the flexural surfaces of the body and usually begins in childhood. Drug treatment can further be segmented into antihistamines, antibiotics, emollients, corticosteroids, and calcineurin inhibitors. Market Ana…
- 脂漏性皮膚炎治療の世界市場（～2026年） Seborrhoeic dermatitis is a long-term skin disorder. Seborrhoeic dermatitis symptoms include red, scaly, greasy, itchy and inflamed skin. Market Analysis and Insights: Global Seborrheic Dermatitis Treatment Market The global Seborrheic Dermatitis Treatment market size is projected to reach US$ XX mi…
- 放射線皮膚炎治療の世界市場（～2026年） The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation. The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cance…
- アレルギー性接触皮膚炎（ACDS）の世界市場（～2026年） Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The oth…